Sevelamer Hydrochloride
Product Intro
Seviram hydrochloride is a new generation of drug approved by the U.S. Food and Health Inspection Bureau in 1998. Renagel is a brand-new drug in pharmacological classification. It is characterized by macromolecular compounds that do not contain aluminum, calcium or any metal components. Patients take it together with the drug at the same time after three meals. It adsorbs phosphoric acid in the intestinal tract in a manner similar to resin exchange ion, After binding, it is excreted by feces.
Function
It can combine glycosylated products to reduce the level of glycosylated hemoglobin, reduce the level of glycosylated products in serum and cells, and then reduce the level of inflammatory factors within 8 weeks to improve inflammatory response and oxidative stress.
Application
In clinic, high blood phosphorus level may lead to fatal complications in hemodialysis patients, while sviram hydrochloride can combine and remove phosphorus from diet in the digestive tract and normal digestive process, and will not cause hypercalcemia caused by routine treatment.
Copyright © Shanghai Norky Pharmaceutical Co., Ltd. All Rights Reserved 沪ICP备20013299号 Powered by www.300.cn